Fake Drugs Worth ₹ 27.91 Lakh Sent Back To Baddi From Agra, Seized

Solan : A consignment of spurious drugs having a face value of ₹ 27,91,445, manufactured by Baddi-based Trizal Formulation in the name of three renowned companies, was sent back to Baddi by a transport company from Agra following the directions of local drugs officials.

The drugs in 12 boxes had been couriered by kingpin of the spurious drug racket Mohit Bansal on November 21, a day before his arrest, to his wholesale firm MH Pharma in Agra. The officials today seized the consignment from the godown of the transport company TCI in Baddi, said State Drugs Controller Navneet Marwaha.

The Drugs Control Administration (DCA) had alerted the Uttar Pradesh DCA about this consignment on December 1. The consignment had remained undelivered as Bansal’s firm was sealed after the spurious drug racket was detected. The drugs were lying with the TCI in Agra.

“The recovered drugs comprise 1,77, 300 spurious tablets of different brands — Montair- 10, Roseday-10 and Glimisave-M2 tablets. The transport agency was directed to return the consignment as it purportedly contained spurious drugs. Two Drugs Inspectors escorted the transport vehicle from Agra to Baddi to avoid any tampering.”

Marwaha added that the arrest of the accused and timely action against the wholesale firm at Agra by the HP Drugs Control Department prevented the sale of spurious tablets.

The seized drugs comprise drugs used for common ailments. Roseday-10 is used to lower cholesterol, Glimisave-M2 is an anti-diabetic drug and Montair-10 is used by asthma patients. These carried the name of leading companies like Cipla, Eris and USV Private Limited.

Bansal was arrested with a cache of spurious drugs in his car on November 22 near the inter-state barrier at Baddi along with his two associates Atul Gupta and Vijay Kaushal.

  • Related Posts

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Hetero debuts semaglutide generic in emerging markets

    New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework